Article
Noninvasive prenatal testing creates an opportunity for antenatal treatment of Down syndrome
17 Apr 2013
Abstract excerpt
Trisomy 21 (T21) is the most common autosomal aneuploidy that is associated with intellectual disability. It is the focus of many prenatal screening programs across the globe. Pregnant women who receive a prenatal diagnosis of T21 in their fetus currently have the option of continuing or terminating their pregnancy, but no fetal treatment is available. In this paper, we review compelling morphogenetic, cellular,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
